Acute hepatic porphyrias-A guide for hepatologists

被引:2
作者
Moghe, Akshata [1 ]
McGuire, Brendan M. [2 ]
Levy, Cynthia [3 ]
机构
[1] Univ Texas Hlth Sci Ctr Houston, Dept Internal Med, Div Gastroenterol Hepatol & Nutr, Houston, TX USA
[2] Univ Alabama Birmingham, Dept Internal Med, Div Gastroenterol & Hepatol, Birmingham, AL USA
[3] Univ Miami, Dept Med, Div Digest Hlth & Liver Dis, Miami, FL USA
关键词
ACUTE INTERMITTENT PORPHYRIA; DELTA-AMINOLEVULINIC-ACID; PORPHOBILINOGEN DEAMINASE GENE; HEPATOCELLULAR-CARCINOMA; LIVER-TRANSPLANTATION; VARIEGATE PORPHYRIA; RECURRENT ATTACKS; RECOMMENDATIONS; DEHYDRATASE; DIAGNOSIS;
D O I
10.1097/HEP.0000000000000880
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
The acute hepatic porphyrias (AHPs) are a group of rare, inherited disorders of the heme biosynthesis pathway, usually manifesting with attacks of acute abdominal pain and other neurovisceral symptoms, with or without cutaneous manifestations. AHPs are characterized by the accumulation of porphyrin precursors, porphobilinogen, and/or aminolevulinic acid, in the blood. The diagnosis is often missed or delayed due to both inadequate testing and the improper use of available laboratory tests. In this review, we describe the various clinical presentations of the 4 AHPs, elucidate the approach to diagnosis, and provide recommendations for immediate and long-term management. We also describe the different complications that can occur with long-standing AHP, including the development of HCC. The AHPs are very treatable conditions, with excellent outcomes if diagnosed and treated early. A high index of suspicion for the presence of these disorders, along with accurate testing and timely treatment, will help reduce the burden of disease and prevent irreversible complications in patients with AHP.
引用
收藏
页数:16
相关论文
共 105 条
[1]   δ-Aminolevulinate dehydratase (ALAD) porphyria:: The first case in North America with two novel ALAD mutations [J].
Akagi, R ;
Kato, N ;
Inoue, R ;
Anderson, KE ;
Jaffe, EK ;
Sassa, S .
MOLECULAR GENETICS AND METABOLISM, 2006, 87 (04) :329-336
[2]   Dual gene defects involving δ-aminolaevulinate dehydratase and coproporphyrinogen oxidase in a porphyria patient [J].
Akagi, R ;
Inoue, R ;
Muranaka, S ;
Tahara, T ;
Taketani, S ;
Anderson, KE ;
Phillips, JD ;
Sassa, S .
BRITISH JOURNAL OF HAEMATOLOGY, 2006, 132 (02) :237-243
[3]   Hepatocellular carcinoma in patients with acute hepatic porphyria:: frequency of occurrence and related factors [J].
Andant, C ;
Puy, H ;
Bogard, C ;
Faivre, J ;
Soulé, JC ;
Nordmann, Y ;
Deybach, JC .
JOURNAL OF HEPATOLOGY, 2000, 32 (06) :933-939
[4]  
Anderson K., 1996, Cecil Textbook of Medicine: The Porphyrias, V20th Edition ed
[5]   Acute hepatic porphyrias: Current diagnosis & management [J].
Anderson, Karl E. .
MOLECULAR GENETICS AND METABOLISM, 2019, 128 (03) :219-227
[6]   A GONADOTROPIN-RELEASING HORMONE ANALOG PREVENTS CYCLICAL ATTACKS OF PORPHYRIA [J].
ANDERSON, KE ;
SPITZ, IM ;
BARDIN, CW ;
KAPPAS, A .
ARCHIVES OF INTERNAL MEDICINE, 1990, 150 (07) :1469-1474
[7]   Reconstitution of hematin for intravenous infusion [J].
Anderson, KE ;
Bonkovsky, HL ;
Bloomer, JR ;
Shedlofsky, SI .
ANNALS OF INTERNAL MEDICINE, 2006, 144 (07) :537-538
[8]   Recommendations for the diagnosis and treatment of the acute porphyrias [J].
Anderson, KE ;
Bloomer, JR ;
Bonkovsky, HL ;
Kushner, JP ;
Pierach, CA ;
Pimstone, NR ;
Desnick, RJ .
ANNALS OF INTERNAL MEDICINE, 2005, 142 (06) :439-450
[9]   STUDIES IN PORPHYRIA .8. RELATIONSHIP OF THE 5-ALPHA-REDUCTIVE METABOLISM OF STEROID-HORMONES TO CLINICAL EXPRESSION OF THE GENETIC DEFECT IN ACUTE INTERMITTENT PORPHYRIA [J].
ANDERSON, KE ;
BRADLOW, HL ;
SASSA, S ;
KAPPAS, A .
AMERICAN JOURNAL OF MEDICINE, 1979, 66 (04) :644-650
[10]   Renal symptomatology in patients with acute intermittent porphyria. A population-based study [J].
Andersson, C ;
Wikberg, A ;
Stegmayr, B ;
Lithner, F .
JOURNAL OF INTERNAL MEDICINE, 2000, 248 (04) :319-325